TCA
CVS icon

Transcend Capital Advisors’s CVS Health CVS Stock Holding History

Transcend Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
12,282
+2,444
+25% +$218K 0.09% 219
2026
Q1 		$707K Sell
9,838
-820
-8% -$63.2K 0.06% 305
2025
Q4 		$846K Sell
10,658
-5,079
-32% -$400K 0.07% 258
2025
Q3 		$1.19M Buy
15,737
+2,595
+20% +$178K 0.08% 221
2025
Q2 		$907K Sell
13,142
-6,240
-32% -$409K 0.07% 247
2025
Q1 		$1.31M Buy
19,382
+5,428
+39% +$325K 0.09% 216
2024
Q4 		$626K Sell
13,954
-5,287
-27% -$297K 0.05% 304
2024
Q3 		$1.21M Sell
19,241
-3,398
-15% -$198K 0.08% 235
2024
Q2 		$1.34M Buy
22,639
+4,826
+27% +$302K 0.1% 213
2024
Q1 		$1.42M Buy
17,813
+2,044
+13% +$156K 0.11% 186
2023
Q4 		$1.25M Sell
15,769
-1,164
-7% -$82.8K 0.11% 183
2023
Q3 		$1.18M Buy
16,933
+4,678
+38% +$331K 0.12% 182
2023
Q2 		$847K Sell
12,255
-3,292
-21% -$234K 0.08% 229
2023
Q1 		$1.16M Sell
15,547
-2,039
-12% -$171K 0.12% 179
2022
Q4 		$1.64M Buy
17,586
+404
+2% +$39K 0.18% 135
2022
Q3 		$1.64M Sell
17,182
-1,425
-8% -$141K 0.18% 133
2022
Q2 		$1.72M Buy
18,607
+1,132
+6% +$110K 0.18% 136
2022
Q1 		$1.77M Sell
17,475
-914
-5% -$96K 0.16% 148
2021
Q4 		$1.9M Buy
18,389
+2,085
+13% +$193K 0.17% 147
2021
Q3 		$1.44M Buy
16,304
+511
+3% +$42.8K 0.13% 173
2021
Q2 		$1.32M Sell
15,793
-289
-2% -$23.7K 0.19% 128
2021
Q1 		$1.21M Sell
16,082
-58
-0.4% -$4.22K 0.15% 155
2020
Q4 		$1.1M Sell
16,140
-9,772
-38% -$636K 0.14% 156
2020
Q3 		$1.51M Buy
25,912
+9,638
+59% +$600K 0.28% 87
2020
Q2 		$1.06M Buy
16,274
+5,312
+48% +$335K 0.34% 75
2020
Q1 		$650K Buy
10,962
+6,701
+157% +$447K 0.19% 119
2019
Q4 		$317K Buy
+4,261
New +$299K 0.09% 174

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Transcend Capital Advisors's CVS Position: Q2 2026 in Review

Transcend Capital Advisors increased its CVS Health (CVS) stake by 25% in Q2 2026, buying an estimated $218K and bringing the position to 12,282 shares worth $1.27M. The position accounts for 0.09% of the portfolio, ranked #219.

Transcend Capital Advisors first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.9M in Q4 2021. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Transcend Capital Advisors held 12,282 shares of CVS Health worth $1.27M as of Q2 2026.
  • Transcend Capital Advisors bought 2,444 CVS Health shares in Q2 2026, an estimated $218K.
  • CVS Health made up 0.09% of Transcend Capital Advisors's portfolio in Q2 2026, its #219 holding.
  • Transcend Capital Advisors first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • Transcend Capital Advisors's CVS Health position peaked at $1.9M in Q4 2021.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.